| Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm) (NCT01788319) | Universitaire Ziekenhuizen KU Leuven | 2013-02-01 |
| A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days (NCT01789736) | Aerie Pharmaceuticals | 2013-02-01 |
| Ocular Blood Flow in Glaucoma Patients - the Leuven Eye Study (NCT01840202) | Universitaire Ziekenhuizen KU Leuven | 2013-02-01 |
| Study on the Oxygen Saturation in Pulsating and Non-pulsating Central Retinal Veins (NCT01794442) | Universitaire Ziekenhuizen KU Leuven | 2013-01-01 |
| Study on Ocular Blood Flow and the Orbital Cerebrospinal Fluid Pressure in Glaucoma (NCT01802463) | Universitaire Ziekenhuizen KU Leuven | 2013-01-01 |
| Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT01749930) | Bausch & Lomb Incorporated | 2013-01-01 |
| A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension (NCT01781962) | Allergan | 2013-01-01 |
| Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH (NCT01721707) | Adapt Produtos Oftalmológicos Ltda. | 2012-12-01 |
| Prevalence of Dyschromatopsia in Glaucoma Patients (NCT01994564) | Massachusetts Eye and Ear Infirmary | 2012-11-01 |
| Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure (NCT01731002) | Aerie Pharmaceuticals | 2012-11-01 |
| BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT01707381) | Bausch & Lomb Incorporated | 2012-11-01 |
| A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months (NCT01699464) | Aerie Pharmaceuticals | 2012-10-01 |
| Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerectomy (NCT01887873) | Croma-Pharma GmbH | 2012-07-01 |
| Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma (NCT01739244) | Sylentis, S.A. | 2012-07-01 |
| Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure (NCT01779778) | University of Colorado, Denver | 2012-04-01 |
| Study of AR-13324 in Patients With Elevated Intraocular Pressure (NCT01528787) | Aerie Pharmaceuticals | 2012-03-01 |
| Efficacy of Changing to TRAVATAN® From Prior Therapy (NCT01510145) | Alcon Research | 2012-02-01 |
| Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery (NCT03201354) | Institut Catala de Retina | 2012-02-01 |
| Travacom Post Marketing Surveillance Study (NCT01510132) | Alcon Research | 2012-01-01 |
| Efficacy of Changing to TRAVATAN® From Prior Therapy (NCT01493427) | Alcon Research | 2011-12-01 |
| Comparison of Gonioscopy With Cirrus and Visante (NCT01895686) | Wills Eye | 2011-11-01 |
| Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004% (NCT01452009) | Alcon Research | 2011-11-01 |
| Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (NCT01568008) | Allergan | 2011-10-01 |
| Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) (NCT01464424) | Alcon Research | 2011-10-01 |
| Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery (NCT01455467) | Glaukos Corporation | 2011-09-01 |
| Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost (NCT01443988) | Glaukos Corporation | 2011-09-01 |
| A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2% (NCT01426867) | Alcon Research | 2011-09-01 |
| Waveform Analysis of the Doppler Curve of Ophthalmic Arteries in Glaucoma Patients (NCT01487655) | Universitaire Ziekenhuizen KU Leuven | 2011-09-01 |
| Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost (NCT01444040) | Glaukos Corporation | 2011-09-01 |
| Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents (NCT01456390) | Glaukos Corporation | 2011-09-01 |
| Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada (NCT01415401) | Alcon Research | 2011-09-01 |
| Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty (NCT01444105) | Glaukos Corporation | 2011-09-01 |
| Impact of a Tolerability Switch to Dorzolamide/Timolol Preservative-free Fixed Combination on Ocular Surface Symptoms (NCT01923714) | Universitaire Ziekenhuizen KU Leuven | 2011-08-01 |
| Efficacy of Changing to DUOTRAV® From Prior Therapy (NCT01327599) | Alcon Research | 2011-08-01 |
| Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C (NCT01312454) | Alcon Research | 2011-06-01 |
| 24-hour Efficacy of AR-12286 (NCT01330979) | Aerie Pharmaceuticals | 2011-05-01 |
| Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension (NCT01309204) | Alcon Research | 2011-05-01 |
| Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension (NCT01310777) | Alcon Research | 2011-05-01 |
| DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5% (NCT01342081) | Santen Pharmaceutical Co., Ltd. | 2011-05-01 |
| DE-111 Against Timolol Ophthalmic Solution 0.5% (NCT01342094) | Santen Pharmaceutical Co., Ltd. | 2011-05-01 |
| Intraocular Pressure, Blood Pressure, Ocular Perfusion and Blood Flow Fluctuations in Glaucoma Patients (NCT01304264) | Lithuanian University of Health Sciences | 2011-03-01 |
| Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations (NCT01306461) | Santen Oy | 2011-03-01 |
| Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies (NCT01292460) | Santen Oy | 2011-02-01 |
| Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2% (NCT01297517) | Alcon Research | 2011-02-01 |
| Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma (NCT01645319) | Agency for Healthcare Research and Quality (AHRQ) | 2011-02-01 |
| Safety and Efficacy of Canaloplasty and Non-penetrating Deep Sclerectomy With Phacoemulsification to Treat Glaucoma and Cataract (NCT01726543) | Military Institute od Medicine National Research Institute | 2011-02-01 |
| Divided Dose of TRAVATAN® (NCT01298687) | Alcon Research | 2011-02-01 |
| Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT01279083) | Santen Inc. | 2011-01-01 |
| Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation (NCT01391247) | Universitaire Ziekenhuizen KU Leuven | 2011-01-01 |
| Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension (NCT00945958) | Sun Pharma Advanced Research Company Limited | 2010-11-01 |
| A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (NCT01229982) | Mati Therapeutics Inc. | 2010-10-01 |
| Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension (NCT01157364) | Allergan | 2010-09-23 |
| Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics (NCT01342406) | University of Nebraska | 2010-09-01 |
| Surgical Treatment of Refractory Open Angle Glaucoma (NCT01212861) | iScience Interventional Corporation | 2010-08-01 |
| The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma (NCT01369771) | FinnMedi Oy | 2010-08-01 |
| Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension (NCT00947661) | Sun Pharma Advanced Research Company Limited | 2010-07-01 |
| Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops (NCT01087671) | Santen Oy | 2010-04-01 |
| ELAZOP Switching Study in Korea (NCT01055366) | Alcon Research | 2010-03-01 |
| Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension (NCT01068964) | Allergan | 2010-02-01 |
| Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED) (NCT01026831) | Merck Sharp & Dohme LLC | 2010-01-06 |
| Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00872651) | Alcon Research | 2010-01-01 |
| A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG (NCT01037036) | Mati Therapeutics Inc. | 2009-12-01 |
| Trabectome Versus Trabeculectomy With Mitomycin C in Patients With Open Angle Glaucoma (NCT00901108) | University of Alberta | 2009-11-01 |
| Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany (NCT01174420) | Aeon Astron Europe B.V. | 2009-11-01 |
| Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination (NCT00961649) | Alcon Research | 2009-10-01 |
| Safety and Efficacy of a Drug Delivery System in Glaucoma (NCT01016691) | Vistakon Pharmaceuticals | 2009-10-01 |
| Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure (NCT00941525) | Aristotle University Of Thessaloniki | 2009-09-01 |
| Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00928590) | Alcon Research | 2009-07-01 |
| Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00761709) | Alcon Research | 2009-07-01 |
| Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health (NCT00892762) | Alcon Research | 2009-06-01 |
| Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications (NCT01511094) | Federal University of Minas Gerais | 2009-06-01 |
| Equivalence Study of Dorzolamide 2% Eye Drops Solution (NCT00878917) | Alfred E. Tiefenbacher (GmbH & Co. KG) | 2009-04-01 |
| Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy (NCT00844389) | Universidad de Valparaiso | 2009-04-01 |
| Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension (NCT00868894) | Santen Inc. | 2009-03-01 |
| Safety and Efficacy Study of DuoTrav APS Versus DuoTrav (NCT00862472) | Alcon Research | 2009-03-01 |
| DuoTrav® Eye Drops As Replacement Therapy Program (NCT00828906) | Alcon Research | 2009-02-01 |
| A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs (NCT00823043) | Vistakon Pharmaceuticals | 2009-01-01 |
| A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma (NCT00887029) | Ophthalmic Consultants Centres, Canada | 2009-01-01 |
| The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG) (NCT00815373) | Meir Medical Center | 2008-12-01 |
| Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN (NCT00798759) | Alcon Research | 2008-12-01 |
| A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension (NCT00788541) | Alcon Research | 2008-12-01 |
| Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health (NCT00761319) | Alcon Research | 2008-10-01 |
| Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension (NCT00759239) | Alcon Research | 2008-09-01 |
| Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00690794) | Alcon Research | 2008-07-01 |
| Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG) (NCT00698945) | Bp Consulting, Inc | 2008-06-01 |
| Safety and Efficacy of Travoprost/Timolol BAC-free (NCT00760539) | Alcon Research | 2008-06-01 |
| Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00691717) | Alcon Research | 2008-06-01 |
| A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00672997) | Alcon Research | 2008-05-01 |
| A Multi-Dose Study With a Treatment for Open-Angle Glaucoma (NCT00705770) | Alcon Research | 2008-05-01 |
| Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative (NCT00803387) | United States Air Force | 2008-04-01 |
| Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00670033) | Alcon Research | 2008-04-01 |
| Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP) (NCT00691639) | Alcon Research | 2008-03-01 |
| Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension (NCT00650338) | Santen Inc. | 2008-03-01 |
| Evaluation of Pascal Laser Trabeculoplaty (NCT00838721) | Santa Clara Valley Health & Hospital System | 2008-03-01 |
| 24 Hour IOP Lowering Efficacy of AL-3789 (NCT00643669) | Alcon Research | 2008-02-01 |
| Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops (NCT00596791) | Santen Oy | 2008-01-01 |
| PASCAL Trabeculoplasty (NCT00804323) | Asociación para Evitar la Ceguera en México | 2007-12-01 |
| Adjunctive Study of AL-37807 Ophthalmic Suspension (NCT00620256) | Alcon Research | 2007-11-01 |
| Adherence Assessment With Travalert Dosing Aid (NCT00508469) | Alcon Research | 2007-10-01 |
| Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost (NCT00637130) | Alcon Research | 2007-10-01 |